Literature DB >> 20620333

Efficacy of ethanol locks in reducing central venous catheter infections in pediatric patients with intestinal failure.

Brian A Jones1, Melissa A Hull, Denise S Richardson, David Zurakowski, Kathleen Gura, Shimae C Fitzgibbons, Debora Duro, Clifford W Lo, Christopher Duggan, Tom Jaksic.   

Abstract

PURPOSE: We sought to determine whether a regimen of 70% ethanol locks could reduce the rate of central venous catheter (CVC) infections in parenteral nutrition-dependent children with intestinal failure.
METHODS: We performed a retrospective review of 23 parenteral nutrition-dependent children in our multidisciplinary intestinal rehabilitation clinic who started ethanol lock therapy between September 2007 and June 2009. The treatment regimen consisted of a 70% ethanol lock instilled 3 times per week in each catheter lumen. The rate of CVC infections before and after initiation of ethanol lock therapy was compared using the Wilcoxon signed ranks test with significance set at P < .05.
RESULTS: The most common diagnoses leading to intestinal failure were necrotizing enterocolitis (26.1%), gastroschisis (21.7%), and intestinal atresia (14.3%). Ethanol locks were well tolerated with no reported adverse side effects. The infection rate decreased from 9.9 per 1000 catheter days prior to initiation of ethanol locks to 2.1 per 1000 catheter days during therapy (P = .03).
CONCLUSIONS: A regimen of ethanol lock therapy administered three days per week appears to be a safe and effective means of reducing the rate of CVC infections in parenteral nutrition-dependent children with intestinal failure. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20620333      PMCID: PMC4547776          DOI: 10.1016/j.jpedsurg.2010.02.099

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  21 in total

1.  Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial.

Authors:  K J Henrickson; R A Axtell; S M Hoover; S M Kuhn; J Pritchett; S C Kehl; J P Klein
Journal:  J Clin Oncol       Date:  2000-03       Impact factor: 44.544

Review 2.  Biofilms: survival mechanisms of clinically relevant microorganisms.

Authors:  Rodney M Donlan; J William Costerton
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

3.  Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.

Authors:  Naomi P O'Grady; Mary Alexander; E Patchen Dellinger; Julie L Gerberding; Stephen O Heard; Dennis G Maki; Henry Masur; Rita D McCormick; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne Randolph; Robert A Weinstein
Journal:  MMWR Recomm Rep       Date:  2002-08-09

4.  Improved survival in a multidisciplinary short bowel syndrome program.

Authors:  Biren P Modi; Monica Langer; Y Avery Ching; Clarissa Valim; Stephen D Waterford; Julie Iglesias; Debora Duro; Clifford Lo; Tom Jaksic; Christopher Duggan
Journal:  J Pediatr Surg       Date:  2008-01       Impact factor: 2.545

Review 5.  Irreversible intestinal failure.

Authors:  Olivier Goulet; Frank Ruemmele; Florence Lacaille; Virginie Colomb
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-03       Impact factor: 2.839

6.  A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients.

Authors:  Joanne Sanders; Alan Pithie; Peter Ganly; Lois Surgenor; Rachel Wilson; Eileen Merriman; Gail Loudon; Rhonda Judkins; Stephen Chambers
Journal:  J Antimicrob Chemother       Date:  2008-07-11       Impact factor: 5.790

7.  Inhibition by ethanol of the growth of biofilm and dispersed microcosm dental plaques.

Authors:  C H Sissons; L Wong; T W Cutress
Journal:  Arch Oral Biol       Date:  1996-01       Impact factor: 2.633

8.  Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients.

Authors:  Marianne T Opilla; Donald F Kirby; Michael B Edmond
Journal:  JPEN J Parenter Enteral Nutr       Date:  2007 Jul-Aug       Impact factor: 4.016

9.  Two-hit rat model of short bowel syndrome and sepsis: independent of total parenteral nutrition, short bowel syndrome is proinflammatory and injurious to the liver.

Authors:  Charles J Aprahamian; Min Chen; Yingkui Yang; Robin G Lorenz; Carroll M Harmon
Journal:  J Pediatr Surg       Date:  2007-06       Impact factor: 2.545

10.  Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome.

Authors:  Elisabeth Mouw; Katherine Chessman; Aaron Lesher; Edward Tagge
Journal:  J Pediatr Surg       Date:  2008-06       Impact factor: 2.545

View more
  14 in total

1.  Central venous catheter repair is associated with an increased risk of bacteremia and central line-associated bloodstream infection in pediatric patients.

Authors:  Ingrid S Lundgren; Chuan Zhou; Frances R Malone; Nancy G McAfee; Soren Gantt; Danielle M Zerr
Journal:  Pediatr Infect Dis J       Date:  2012-04       Impact factor: 2.129

Review 2.  Short bowel syndrome in the NICU.

Authors:  Sachin C Amin; Cleo Pappas; Hari Iyengar; Akhil Maheshwari
Journal:  Clin Perinatol       Date:  2013-01-17       Impact factor: 3.430

3.  Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy.

Authors:  Ashwini Chauhan; David Lebeaux; Jean-Marc Ghigo; Christophe Beloin
Journal:  Antimicrob Agents Chemother       Date:  2012-10-01       Impact factor: 5.191

4.  Hidden morbidity of ethanol lock therapy.

Authors:  Teerin T Meckmongkol; Caitlyn Costanzo; Sean Ciullo; Rajeev Prasad; L Grier Arthur
Journal:  Pediatr Surg Int       Date:  2017-10-16       Impact factor: 1.827

Review 5.  Diagnosis and management of catheter-related bloodstream infections in patients on home parenteral nutrition.

Authors:  Ashley Bond; Paul Chadwick; Trevor R Smith; Jeremy M D Nightingale; Simon Lal
Journal:  Frontline Gastroenterol       Date:  2019-02-12

6.  Neurodevelopmental and Cognitive Outcomes in Children With Intestinal Failure.

Authors:  Patrick M Chesley; Sabrina E Sanchez; Lilah Melzer; Assaf P Oron; Simon P Horslen; F Curt Bennett; Patrick J Javid
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-07       Impact factor: 2.839

7.  Ethanol Lock Efficacy and Associated Complications in Children With Intestinal Failure.

Authors:  Ethan A Mezoff; Lin Fei; Misty Troutt; Kim Klotz; Samuel A Kocoshis; Conrad R Cole
Journal:  JPEN J Parenter Enteral Nutr       Date:  2015-02-23       Impact factor: 4.016

8.  Prevention and treatment of intestinal failure-associated liver disease in children.

Authors:  Bram P Raphael; Christopher Duggan
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

9.  Systematic Review and Meta-Analysis of the Utilization of Ethanol Locks in Pediatric Patients With Intestinal Failure.

Authors:  Riad Rahhal; Maisam A Abu-El-Haija; Lin Fei; Dawn Ebach; Sarah Orkin; Elizabeth Kiscaden; Conrad R Cole
Journal:  JPEN J Parenter Enteral Nutr       Date:  2017-12-19       Impact factor: 4.016

10.  Natural history of pediatric intestinal failure: initial report from the Pediatric Intestinal Failure Consortium.

Authors:  Robert H Squires; Christopher Duggan; Daniel H Teitelbaum; Paul W Wales; Jane Balint; Robert Venick; Susan Rhee; Debra Sudan; David Mercer; J Andres Martinez; Beth A Carter; Jason Soden; Simon Horslen; Jeffrey A Rudolph; Samuel Kocoshis; Riccardo Superina; Sharon Lawlor; Tamara Haller; Marcia Kurs-Lasky; Steven H Belle
Journal:  J Pediatr       Date:  2012-05-11       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.